"It is difficult to overstate the extraordinary impact Laura has had on AbbVie over the past 10 years," CEO Richard Gonzalez said.
October 18, 2022 at 08:11 AM
2 minute read
Laura Schumacher is retiring from the pharmaceuticals giant AbbVie, where she has been legal chief since the company launched as a spinoff from Abbott Laboratories in 2013.
North Chicago, Illinois-based AbbVie, maker of the mega-blockbuster immunosuppressant Humira, on Monday announced Schumacher’s planned departure and said she would be succeeded by Deputy General Counsel Perry Siatis.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Predictive reporting, trend analysis, peer guidance and a practical playbook to help genetal counsels succeed in their increasingly high stakes roles as risk managers and corporate strategists
AbbVie’s top-selling drug is Humira. Courtesy photo
Laura Schumacher. Courtesy photo
